$DSS
DSS, INC. Stock $dss

$dss Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000149315223028533 Filed on August 14, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$4.182M	$7.233M
YoY Change	-64.74%	-38.55%
Cost Of Revenue	$6.070M	$4.832M
YoY Change	-46.6%	-37.0%
Gross Profit	-$1.890M	$2.401M
YoY Change	-482.59%	-41.45%
Gross Profit Margin	-45.19%	33.2%
Selling, General & Admin	$3.213M	$8.851M
YoY Change	-78.11%	-42.09%
% of Gross Profit		368.64%
Research & Development	$240.0K	$266.0K
YoY Change	-27.49%	29.13%
% of Gross Profit		11.08%
Depreciation & Amortization	$1.500M	$1.314M
YoY Change	-48.74%	-58.4%
% of Gross Profit		54.73%
Operating Expenses	$9.285M	$13.68M
YoY Change	-64.35%	-40.39%
Operating Profit	-$5.103M	-$6.450M
YoY Change	-64.02%	-42.32%
Interest Expense	$51.00K	$138.0K
YoY Change	-91.58%	14.05%
% of Operating Profit
Other Income/Expense, Net	-$44.00K	$147.0K
YoY Change	-101.21%	-93.73%
Pretax Income	-$6.681M	-$37.72M
YoY Change	-73.06%	597.28%
Income Tax
% Of Pretax Income
Net Earnings	-$4.342M	-$37.92M
YoY Change	-82.49%	715.2%
Net Earnings / Revenue	-103.83%	-524.31%
Basic Earnings Per Share	-$0.03	-$0.27
Diluted Earnings Per Share	-$0.03	-$0.27
COMMON SHARES
Basic Shares Outstanding	140.3M shares	140.3M shares
Diluted Shares Outstanding	140.3M shares	140.1M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.900M	$10.18M
YoY Change	-69.8%	-76.83%
Cash & Equivalents	$6.897M	$10.03M
Short-Term Investments		$148.0K
Other Short-Term Assets	$1.200M	$2.723M
YoY Change	-58.59%	26.12%
Inventory	$3.930M	$5.300M
Prepaid Expenses
Receivables	$3.136M	$2.468M
Other Receivables	$9.300M	$9.269M
Total Short-Term Assets	$24.40M	$29.79M
YoY Change	-56.16%	-60.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$12.35M	$12.44M
YoY Change	-23.12%	-22.28%
Goodwill	$57.88M	$57.88M
YoY Change	2.25%	2.25%
Intangibles
YoY Change
Long-Term Investments	$134.0K	$139.0K
YoY Change	-89.89%	-85.85%
Other Assets	$246.0K	$261.0K
YoY Change	-82.34%	-67.42%
Total Long-Term Assets	$172.1M	$175.1M
YoY Change	-17.72%	-15.89%
TOTAL ASSETS
Total Short-Term Assets	$24.40M	$29.79M
Total Long-Term Assets	$172.1M	$175.1M
Total Assets	$196.6M	$204.9M
YoY Change	-25.8%	-27.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.924M	$3.046M
YoY Change	-27.77%	44.22%
Accrued Expenses	$3.500M	$3.713M
YoY Change	-71.88%	-70.26%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$46.64M	$47.21M
YoY Change	598.17%	1.06%
Total Short-Term Liabilities	$53.47M	$55.49M
YoY Change	126.86%	-10.08%
LONG-TERM LIABILITIES
Long-Term Debt	$7.747M	$7.218M
YoY Change	-84.56%	-63.11%
Other Long-Term Liabilities	$507.0K	$507.0K
YoY Change	0.0%	0.0%
Total Long-Term Liabilities	$8.254M	$7.725M
YoY Change	-83.71%	-61.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$53.47M	$55.49M
Total Long-Term Liabilities	$8.254M	$7.725M
Total Liabilities	$61.73M	$63.22M
YoY Change	-16.86%	-22.7%
SHAREHOLDERS EQUITY
Retained Earnings	-$225.9M	-$221.5M
YoY Change	34.92%	50.49%
Common Stock	$2.804M	$2.804M
YoY Change	0.9%	40.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$94.30M	$98.64M
YoY Change
Total Liabilities & Shareholders Equity	$196.6M	$204.9M
YoY Change	-25.8%	-27.6%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$4.342M	-$37.92M
YoY Change	-82.49%	715.2%
Depreciation, Depletion And Amortization	$1.500M	$1.314M
YoY Change	-48.74%	-58.4%
Cash From Operating Activities	-$1.320M	-$5.516M
YoY Change	-85.81%	-29.97%
INVESTING ACTIVITIES
Capital Expenditures	$180.0K	-$98.00K
YoY Change	-132.55%	188.24%
Acquisitions
YoY Change
Other Investing Activities	-$1.310M	$1.741M
YoY Change	-87.93%	-270.85%
Cash From Investing Activities	-$1.490M	$1.839M
YoY Change	-86.93%	-274.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-320.0K	-22.00K
YoY Change	-18.37%	-97.65%
NET CHANGE
Cash From Operating Activities	-1.320M	-5.516M
Cash From Investing Activities	-1.490M	1.839M
Cash From Financing Activities	-320.0K	-22.00K
Net Change In Cash	-3.130M	-3.699M
YoY Change	-85.17%	-62.51%
FREE CASH FLOW
Cash From Operating Activities	-$1.320M	-$5.516M
Capital Expenditures	$180.0K	-$98.00K
Free Cash Flow	-$1.500M	-$5.418M
YoY Change	-82.86%	-30.92%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent		usd
	DSS	Gain On Allowance For Obsolescence Of Inventory GainOnAllowanceForObsolescenceOfInventory		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0000771999
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent		usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent		usd
CY2022Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
	us-gaap	Dividend Income Operating DividendIncomeOperating		usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q2	DSS	Provision For Loan Losses ProvisionForLoanLosses		usd
	DSS	Provision For Loan Losses ProvisionForLoanLosses		usd
CY2023Q2	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
CY2022Q2	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges		usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations		usd
	DSS	Payments To Acquire Real Estates PaymentsToAcquireRealEstates		usd
	DSS	Proceeds From Repayment Of Marketable Securities ProceedsFromRepaymentOfMarketableSecurities		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations		usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2022Q2	DSS	Revenue On Commission Income RevenueOnCommissionIncome		usd
	DSS	Revenue On Commission Income RevenueOnCommissionIncome		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-32146
	dei	Entity Registrant Name EntityRegistrantName	DSS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	16-1229730
	dei	Entity Address Address Line1 EntityAddressAddressLine1	275 Wiregrass Pkwy
	dei	Entity Address City Or Town EntityAddressCityOrTown	West Henrietta
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	14586
	dei	City Area Code CityAreaCode	(585)
	dei	Local Phone Number LocalPhoneNumber	325-3610
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, $0.02 par value per share
	dei	Trading Symbol TradingSymbol	DSS
	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	140264250	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10033000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19290000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2468000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7564000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	5300000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7721000	usd
CY2023Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1524000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	9269000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	11719000	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1199000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1700000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	29793000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	47994000	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12438000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13391000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	53997000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	55029000	usd
CY2023Q2	us-gaap	Other Investments OtherInvestments	1163000	usd
CY2022Q4	us-gaap	Other Investments OtherInvestments	1534000	usd
CY2023Q2	us-gaap	Equity Method Investments EquityMethodInvestments	139000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	162000	usd
CY2023Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	11575000	usd
CY2022Q4	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	27307000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	1112000	usd
CY2022Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	922000	usd
CY2023Q2	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	480000	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	261000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2699000	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7515000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	8219000	usd
CY2023Q2	us-gaap	Goodwill Goodwill	57880000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	60919000	usd
CY2023Q2	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	28508000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	30740000	usd
CY2023Q2	us-gaap	Assets Assets	204861000	usd
CY2022Q4	us-gaap	Assets Assets	248916000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3046000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5914000	usd
CY2023Q2	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	3080000	usd
CY2022Q4	DSS	Accrued Expenses And Deferred Revenue Current AccruedExpensesAndDeferredRevenueCurrent	19341000	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	396000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	477000	usd
CY2023Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1129000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	633000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	796000	usd
CY2023Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	47206000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	47161000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	55490000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	73689000	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	7218000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	10181000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7120000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7820000	usd
CY2023Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	59000	usd
CY2023Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	507000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	507000	usd
CY2023Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	38000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	38000	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.02
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	140264250	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	140264250	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	139017172	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	139017172	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	2804000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2779000	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	317369000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	317126000	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-221529000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-194343000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	98644000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	125562000	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	35785000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	31119000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	134429000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	204861000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	248916000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7233000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11771000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19064000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24064000	usd
CY2023Q2	DSS	Printed Products Expenses PrintedProductsExpenses	2421000	usd
CY2022Q2	DSS	Printed Products Expenses PrintedProductsExpenses	2603000	usd
	DSS	Printed Products Expenses PrintedProductsExpenses	7081000	usd
	DSS	Printed Products Expenses PrintedProductsExpenses	6026000	usd
CY2023Q2	DSS	Securities Expenses SecuritiesExpenses	1820000	usd
CY2022Q2	DSS	Securities Expenses SecuritiesExpenses	2551000	usd
	DSS	Securities Expenses SecuritiesExpenses	4340000	usd
	DSS	Securities Expenses SecuritiesExpenses	5124000	usd
CY2023Q2	DSS	Biotechnology Expenses BiotechnologyExpenses	2000	usd
CY2022Q2	DSS	Biotechnology Expenses BiotechnologyExpenses	308000	usd
	DSS	Biotechnology Expenses BiotechnologyExpenses	63000	usd
	DSS	Biotechnology Expenses BiotechnologyExpenses	308000	usd
CY2023Q2	DSS	Direct Marketing Expenses DirectMarketingExpenses	516000	usd
CY2022Q2	DSS	Direct Marketing Expenses DirectMarketingExpenses	1990000	usd
	DSS	Direct Marketing Expenses DirectMarketingExpenses	1806000	usd
	DSS	Direct Marketing Expenses DirectMarketingExpenses	4127000	usd
CY2023Q2	DSS	Others Expenses OthersExpenses	73000	usd
CY2022Q2	DSS	Others Expenses OthersExpenses	218000	usd
	DSS	Others Expenses OthersExpenses	75000	usd
	DSS	Others Expenses OthersExpenses	700000	usd
CY2023Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8851000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15283000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17824000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	25639000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	13683000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	22953000	usd
	us-gaap	Operating Expenses OperatingExpenses	31189000	usd
	us-gaap	Operating Expenses OperatingExpenses	41924000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6450000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-11182000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-12125000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17860000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	407000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	139000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	538000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	295000	usd
CY2023Q2	us-gaap	Dividend Income Operating DividendIncomeOperating	8000	usd
	us-gaap	Dividend Income Operating DividendIncomeOperating	12000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	147000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2344000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	175000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	576000	usd
CY2023Q2	us-gaap	Interest Expense InterestExpense	138000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	121000	usd
	us-gaap	Interest Expense InterestExpense	388000	usd
	us-gaap	Interest Expense InterestExpense	1499000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	110000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	110000	usd
CY2023Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-18000	usd
CY2022Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-99000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-22000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-211000	usd
CY2023Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	-27922000	usd
CY2022Q2	us-gaap	Gain Loss On Investments GainLossOnInvestments	3399000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-30790000	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	3823000	usd
CY2023Q2	DSS	Provision For Loan Losses ProvisionForLoanLosses	-3757000	usd
	DSS	Provision For Loan Losses ProvisionForLoanLosses	-3757000	usd
	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	405000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37723000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5410000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-46357000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-14361000	usd
CY2023Q2	us-gaap	Profit Loss ProfitLoss	-37723000	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	-5410000	usd
	us-gaap	Profit Loss ProfitLoss	-46357000	usd
	us-gaap	Profit Loss ProfitLoss	-14361000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	200000	usd
CY2022Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-758000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-398000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1661000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-37923000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-4652000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-45959000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-12700000	usd
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	140140913	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34888054	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	139579043	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85641957	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	140140913	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34888054	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	139579043	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	85641957	shares
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-46357000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-14361000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2647000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6425000	usd
	DSS	Gain On Allowance For Obsolescence Of Inventory GainOnAllowanceForObsolescenceOfInventory	-280000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	268000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	4000	usd
	DSS	Equity Method Investments Gain Loss EquityMethodInvestmentsGainLoss	-22000	usd
	DSS	Equity Method Investments Gain Loss EquityMethodInvestmentsGainLoss	-211000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-30790000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	3823000	usd
	DSS	Change In Right Of Use Assets ChangeInRightOfUseAssets	-774000	usd
	DSS	Change In Right Of Use Assets ChangeInRightOfUseAssets	10202000	usd
	DSS	Change In Right Of Useliabilities ChangeInRightOfUseliabilities	1052000	usd
	DSS	Change In Right Of Useliabilities ChangeInRightOfUseliabilities	-10122000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	56595000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10033000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	43945000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	156681000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	110000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	405000	usd
	DSS	Impairment Of Notes Receivable ImpairmentOfNotesReceivable	3757000	usd
	DSS	Impairment Of Notes Receivable ImpairmentOfNotesReceivable	1745000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2531000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	460000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4707000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-591000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-592000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1307000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-3123000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	312000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3846000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	192000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-15958000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-3036000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-81000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-373000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-18083000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-13947000	usd
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1632000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-19715000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-13947000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	496000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	976000	usd
	DSS	Payments To Acquire Real Estates PaymentsToAcquireRealEstates	689000	usd
	DSS	Proceeds From Repayment Of Marketable Securities ProceedsFromRepaymentOfMarketableSecurities	4805000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	215000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2557000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	11330000	usd
	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	3362000	usd
	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	2327000	usd
	us-gaap	Proceeds From Sale Of Notes Receivable ProceedsFromSaleOfNotesReceivable	863000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	13376000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6412000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	5519000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	169000	usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	2601000	usd
	us-gaap	Proceeds From Repayments Of Other Long Term Debt ProceedsFromRepaymentsOfOtherLongTermDebt	6360000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1518000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2918000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7709000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations	-7625000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Continuing Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectContinuingOperations	-12650000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations	-1632000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19290000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	268000	usd
	DSS	Stock Issued During Period Value Deconsolidation StockIssuedDuringPeriodValueDeconsolidation	23837000	usd
	us-gaap	Profit Loss ProfitLoss	-46357000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	134429000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	198185000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1518000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6221000	usd
	us-gaap	Profit Loss ProfitLoss	-14361000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	191563000	usd
CY2023Q2	DSS	Common Stock Issued And Outstanding Percentage CommonStockIssuedAndOutstandingPercentage	0.81	pure
CY2023Q2	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	29196000	usd
	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	29196000	usd
CY2023Q2	us-gaap	Marketable Securities MarketableSecurities	148000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zA7DIDWU6Iob" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span id="xdx_86E_zxDcvGpW3AX1" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span><b><i> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">- </span></i></b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires the Company to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, the Company evaluates its estimates, including those related to the accounts receivable, convertible notes receivable, inventory, fair values of investments, intangible assets and goodwill, useful lives of intangible assets and property and equipment, fair values of options and warrants to purchase the Company’s common stock, preferred stock, deferred revenue and income taxes, among others. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3390000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	29000	usd
CY2023Q2	us-gaap	Inventory Adjustments InventoryAdjustments	57000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	742000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_846_eus-gaap--ConcentrationRiskCreditRisk_zOHgSJHuI2qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zGqGo7814aq1">Concentration of Credit Risk</span> </i></b><i>-</i> The Company maintains its cash in bank deposit accounts, which at times may exceed federally insured limits. The Company believes it is not exposed to any significant credit risk because of any non-performance by the financial institutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, two customers accounted for approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zoT35m9p4do" title="Concentration risk percentage">14</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zfQdO1sTP7W5" title="Concentration risk percentage">6</span>% of our consolidated revenue and these two customers accounted for approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zsyl3QISa2Mg">36</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20221231__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zoOwO7Kvw8F6">17</span>% of our consolidated trade accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2023, two customers accounted for approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z1KTKpoGVgjj" title="Concentration risk percentage">19</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z0LnsipatZq2" title="Concentration risk percentage">5</span>% of our consolidated revenue and these two customers accounted for approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zTN8wwwhfd21">55</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230101__20230630__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zx01YwZNE6ja">14</span>% of our consolidated trade accounts receivable balance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Cash	10000000.0	usd
CY2023Q2	us-gaap	Cash Cash	10000000.0	usd
CY2023Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	11600000	usd
CY2023Q2	us-gaap	Convertible Debt ConvertibleDebt	9300000	usd
CY2023Q2	us-gaap	Cash Cash	10000000.0	usd
CY2023Q2	us-gaap	Marketable Securities Noncurrent MarketableSecuritiesNoncurrent	11600000	usd
CY2023Q2	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	9300000	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3390000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	29000	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	3226000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6779000	usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	749000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	403000	usd
CY2023Q2	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1381000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1281000	usd
CY2023Q2	us-gaap	Inventory Gross InventoryGross	5357000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	8463000	usd
CY2023Q2	us-gaap	Inventory Adjustments InventoryAdjustments	57000	usd
CY2022Q4	us-gaap	Inventory Adjustments InventoryAdjustments	742000	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	5300000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	7721000	usd
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	25198000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3590000	usd
CY2023Q2	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	21608000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	10033000	usd
CY2023Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	11575000	usd
CY2022	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	59894000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-3659000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	46776000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	19290000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	27307000	usd
CY2022Q4	us-gaap	Investments Investments	179000	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	49076804	usd
CY2022	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-61680088	usd
CY2022	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.55
CY2022	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.55
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	47206000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	3801000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	858000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	901000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	947000	usd
CY2023Q2	DSS	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	711000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	633000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	803000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	794000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	808000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	824000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	4675000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9487000	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1734000	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	7753000	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	633000	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7120000	usd
CY2023Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P13Y10M24D
CY2023Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043	pure
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	2000	shares
	us-gaap	Interest Paid Net InterestPaidNet	1402000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1499000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	5	segments
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7233000	usd
CY2023Q2	DSS	Interest Expenses InterestExpenses	138000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	407000	usd
CY2023Q2	DSS	Net Income Loss From Continuing Operations NetIncomeLossFromContinuingOperations	-37723000	usd
CY2023Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	19000	usd
CY2023Q2	DSS	Identifiable Assets IdentifiableAssets	202744000	usd
CY2023Q2	DSS	Assets Held For Sale AssetsHeldForSale	2004000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11771000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	121000	usd
CY2022Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	139000	usd
CY2022Q2	DSS	Net Income Loss From Continuing Operations NetIncomeLossFromContinuingOperations	-5410000	usd
CY2022Q2	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	269000	usd
CY2022Q2	DSS	Identifiable Assets IdentifiableAssets	282948000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19064000	usd
	DSS	Interest Expenses InterestExpenses	388000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	538000	usd
	DSS	Net Income Loss From Continuing Operations NetIncomeLossFromContinuingOperations	-46357000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	613000	usd
	DSS	Identifiable Assets IdentifiableAssets	202744000	usd
	DSS	Assets Held For Sale AssetsHeldForSale	2004000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	24064000	usd
	us-gaap	Interest Expense InterestExpense	1499000	usd
	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	4000	usd
	DSS	Net Income Loss From Continuing Operations NetIncomeLossFromContinuingOperations	-14361000	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	976000	usd
	DSS	Identifiable Assets IdentifiableAssets	282948000	usd
CY2023Q2	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	3626000	usd
CY2022Q2	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	4048000	usd
	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	9661000	usd
	DSS	Aggregate Value Of Printed Products AggregateValueOfPrintedProducts	7617000	usd
CY2023Q2	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	1572000	usd
CY2022Q2	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	6070000	usd
	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	5566000	usd
	DSS	Revenue On Direct Marketing RevenueOnDirectMarketing	13002000	usd
CY2023Q2	DSS	Revenue On Securities RevenueOnSecurities	1543000	usd
CY2022Q2	DSS	Revenue On Securities RevenueOnSecurities	1508000	usd
	DSS	Revenue On Securities RevenueOnSecurities	3228000	usd
	DSS	Revenue On Securities RevenueOnSecurities	3171000	usd
CY2023Q2	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	197000	usd
CY2022Q2	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	145000	usd
	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	314000	usd
	DSS	Revenue On Net Investment Income RevenueOnNetInvestmentIncome	274000	usd
CY2023Q2	DSS	Revenue On Commission Income RevenueOnCommissionIncome	295000	usd
	DSS	Revenue On Commission Income RevenueOnCommissionIncome	295000	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	17570948	shares

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-23-028533-index-headers.html	Edgar Link	pending
0001493152-23-028533-index.html	Edgar Link	pending
0001493152-23-028533.txt	Edgar Link	pending
0001493152-23-028533-xbrl.zip	Edgar Link	pending
dss-20230630.xsd	Edgar Link	pending
dss_001.jpg	Edgar Link	pending
ex10-1.htm	Edgar Link	pending
ex10-2.htm	Edgar Link	pending
ex1_001.jpg	Edgar Link	pending
ex1_002.jpg	Edgar Link	pending
ex1_003.jpg	Edgar Link	pending
dss-20230630_cal.xml	Edgar Link	unprocessable
dss-20230630_lab.xml	Edgar Link	unprocessable
dss-20230630_pre.xml	Edgar Link	unprocessable
dss-20230630_def.xml	Edgar Link	unprocessable
ex1_004.jpg	Edgar Link	pending
ex1_005.jpg	Edgar Link	pending
ex1_006.jpg	Edgar Link	pending
ex1_007.jpg	Edgar Link	pending
ex1_008.jpg	Edgar Link	pending
ex1_009.jpg	Edgar Link	pending
ex1_010.jpg	Edgar Link	pending
ex1_011.jpg	Edgar Link	pending
ex1_012.jpg	Edgar Link	pending
ex1_013.jpg	Edgar Link	pending
ex1_014.jpg	Edgar Link	pending
ex1_015.jpg	Edgar Link	pending
ex1_016.jpg	Edgar Link	pending
ex1_017.jpg	Edgar Link	pending
ex1_018.jpg	Edgar Link	pending
ex1_019.jpg	Edgar Link	pending
ex1_020.jpg	Edgar Link	pending
ex1_021.jpg	Edgar Link	pending
ex1_022.jpg	Edgar Link	pending
ex1_023.jpg	Edgar Link	pending
ex1_024.jpg	Edgar Link	pending
ex1_025.jpg	Edgar Link	pending
ex1_026.jpg	Edgar Link	pending
ex1_027.jpg	Edgar Link	pending
ex1_028.jpg	Edgar Link	pending
ex1_029.jpg	Edgar Link	pending
ex1_030.jpg	Edgar Link	pending
ex1_031.jpg	Edgar Link	pending
ex1_032.jpg	Edgar Link	pending
ex1_033.jpg	Edgar Link	pending
ex1_034.jpg	Edgar Link	pending
ex1_035.jpg	Edgar Link	pending
ex1_036.jpg	Edgar Link	pending
ex1_037.jpg	Edgar Link	pending
ex1_038.jpg	Edgar Link	pending
ex1_039.jpg	Edgar Link	pending
ex1_040.jpg	Edgar Link	pending
ex1_041.jpg	Edgar Link	pending
ex1_042.jpg	Edgar Link	pending
ex1_043.jpg	Edgar Link	pending
ex1_044.jpg	Edgar Link	pending
ex1_045.jpg	Edgar Link	pending
ex1_046.jpg	Edgar Link	pending
ex1_047.jpg	Edgar Link	pending
ex1_048.jpg	Edgar Link	pending
ex1_049.jpg	Edgar Link	pending
ex1_050.jpg	Edgar Link	pending
ex1_051.jpg	Edgar Link	pending
ex1_052.jpg	Edgar Link	pending
ex1_053.jpg	Edgar Link	pending
ex1_054.jpg	Edgar Link	pending
ex1_055.jpg	Edgar Link	pending
ex1_056.jpg	Edgar Link	pending
ex1_057.jpg	Edgar Link	pending
ex1_058.jpg	Edgar Link	pending
ex1_059.jpg	Edgar Link	pending
ex1_060.jpg	Edgar Link	pending
ex1_061.jpg	Edgar Link	pending
ex1_062.jpg	Edgar Link	pending
ex1_063.jpg	Edgar Link	pending
ex3-1.htm	Edgar Link	pending
ex3-2.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DSS
DSS, INC. Stock $dss

2023 Q3 Form 10-Q Financial Statement

#000149315223028533 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS DSS, INC. Stock $dss

2023 Q3 Form 10-Q Financial Statement

#000149315223028533 Filed on August 14, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DSS
DSS, INC. Stock $dss